Atea Pharmaceuticals Q3 EPS $0.40 Beats $(0.42) Estimate
Benzinga Newsdesk 7 hours ago
NewsEarningsEarnings Beats
Atea Pharmaceuticals (NASDAQ:AVIR) reported quarterly earnings of $0.40 per share which beat the analyst consensus estimate of $(0.42) by 195.24 percent. This is a 175.47 percent increase over losses of $(0.53) per
Atea Pharmaceuticals (NASDAQ:AVIR) reported quarterly earnings of $0.40 per share which beat the analyst consensus estimate of $(0.42) by 195.24 percent. This is a 175.47 percent increase over losses of $(0.53) per share from the same period last year.